Neurodawn Pharmaceutical Co., Ltd.

This was the first study in people to check if a new drug called Y-3 is safe and to see how the body processes it. Twenty healthy adult volunteers in the US took either a single dose of the drug or a placebo (a dummy pill). Researchers closely monitored the participants for side …

This early study aimed to see if a new injectable drug called Y-3 interacts with three common oral medications: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Researchers enrolled 24 healthy Chinese participants to measure how the body pro…